Brian J. North, PhD
Associate Professor
Biomedical Sciences
![B North](/sites/default/files/styles/card_contact/public/2021-12/B%20North.jpg?itok=CFkz_iKL)
Contact
School of Medicine
Biomedical Sciences
Graduate School
Biomedical Sciences (Doctorate)
Biomedical Sciences (Master of Science)
Translational Hearing
CRISS II - Criss 2 - 404
Brian J. North, PhD
Associate Professor
Biomedical Sciences
Learn more about Dr. North's research.
Cancer Research Focus
The North lab studies the interrelationship between aging and cancer. We are particularly interested in the the role of the ubiquitin-proteasome system in targeting tumor suppressors and oncogenes in an age-dependent manner.
Cancer Research Area(s)
- Colon Cancer
- Skin Cancer
- Age Related Cancer Mechanisms
Research Focus
Molecular basis for aging and its impact on age-related disease susceptibility; Understanding the roles of E3 ubiquitin ligases in tumorigenesis; Regulation and function of NAD+-dependent deacetylasesDepartment
Biomedical Sciences
Position
Associate Professor
General
- Pun Renju, Abstract P2037: Bubr1 Is A Critical Regulator Of Cardiac Aging 2023
Publications
- Cellular oncology (Dordrecht)
Zou Qiang, E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities 2023 - Frontiers in cardiovascular medicine
Pun Renju, Role of Connexin 43 phosphorylation on Serine-368 by PKC in cardiac function and disease
9, p. 1080131 - 1080131 2023 - Dai Xiangpeng, Editorial 2022
- Pun Renju, Abstract P1068: BubR1 Is A Novel Regulator Of Cardiac Development And Conduction 2022
- Cell and Bioscience
Bloom Celia R., Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1
11:1 2021 - Nature Communications
Liu Jing, Genetic fusions favor tumorigenesis through degron loss in oncogenes
12:1 2021 - Cell Reports
Shimizu Kouhei, Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
37:6 2021 - Molecular biology reports
Ma Ying, Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation
48:9, p. 6589 - 6601 2021 - Mediators of Inflammation
Kumari Niti, Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
2021 2021 - Nature Cell Biology
Gao Yang, Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
22:9, p. 1064 - 1075 2020 - Biochimica et Biophysica Acta - Reviews on Cancer
Cheng Ji, Functional analysis of deubiquitylating enzymes in tumorigenesis and development
1872:2 2019 - Molecular Oncology
Ma Ying, SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation
13:2, p. 307 - 321 2019 - Biochimica et Biophysica Acta - Reviews on Cancer
Cheng Ji, The emerging role for Cullin 4 family of E3 ligases in tumorigenesis
1871:1, p. 138 - 159 2019 - Protein and Cell
Ci Yanpeng, SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
9:10, p. 879 - 889 2018 - Biochimica et Biophysica Acta - Reviews on Cancer
Cheng Ji, Functional analysis of Cullin 3 E3 ligases in tumorigenesis
1869:1, p. 11 - 28 2018 - Nature
Wang Bin, TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling
545:7654, p. 365 - 369 2017 - PloS one
North Brian J., Enhancement of pomalidomide anti-Tumor response with ACY-241, a selective HDAC6 inhibitor
12:3 2017 - Science Signaling
Nihira Naoe T., Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function
10:466 2017 - Science Signaling
Shimizu Kouhei, The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis
10:460 2017 - Oncotarget
Tan Yuyong, Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6
8:29, p. 47890 - 47901 2017 - Oncotarget
Li Xiaoning, Smurf1 regulation of DAB2IP controls cell proliferation and migration
7:18, p. 26057 - 26069 2016 - Nature Communications
Rumpf Tobias, Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
6 2015 - Oncotarget
Wu Xiaomian, SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination
5:12, p. 4211 - 4221 2014 - Oncotarget
Dai Xiangping, Negative regulation of DAB2IP by Akt and SCFFbw7 pathways
5:10, p. 3307 - 3315 2014 - EMBO Journal
North Brian J., SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
33:13, p. 1438 - 1453 2014 - Neoplasia
Bonezzi Katiuscia, Inhibition of SIRT2 potentiates the anti-motility activity of taxanes
14:9, p. 846 - 854 2012 - Cell Metabolism
Price Nathan L., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function
15:5, p. 675 - 690 2012 - Circulation Research
North Brian J., The intersection between aging and cardiovascular disease
110:8, p. 1097 - 1108 2012 - Proceedings of the National Academy of Sciences of the United States of America
Beirowski Bogdan, Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling
108:43, p. E952 - E961 2011 - Journal of Biological Chemistry
Ahuja Nidhi, Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase
282:46, p. 33583 - 33592 2007 - PloS one
North Brian J., Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis
2:8 2007 - Journal of Biological Chemistry
North Brian J., Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation
282:27, p. 19546 - 19555 2007 - Trends in Biochemical Sciences
North Brian J., Sirtuins
32:1, p. 1 - 4 2007 - Methods
North Brian J., Preparation of enzymatically active recombinant class III protein deacetylases
36:4, p. 338 - 345 2005 - FASEB Journal
Waltregny David, Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle cell contractility
19:8, p. 966 - 968 2005 - PLoS Biology
Pagans Sara, SIRT1 regulates HIV transcription via Tat deacetylation
3:2, p. 210 - 220 2005 - American Journal of Pathology
Waltregny David, Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues
165:2, p. 553 - 564 2004 - European Journal of Histochemistry
Waltregny D., Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells
48:3, p. 273 - 290 2004 - Genome Biology
North Brian J., Sirtuins
5:5 2004 - Molecular Cell
North Brian J., The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
11:2, p. 437 - 444 2003 - Methods in Enzymology
Verdin Eric, Measurement of Mammalian Histone Deacetylase Activity
377, p. 180 - 196 2003 - Journal of Cell Biology
Schwer Björn, The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase
158:4, p. 647 - 657 2002 - Developmental Biology
Verzi Michael P., N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor
249:1, p. 174 - 190 2002
Awards
- National Institutes of Health K01 Career Development Award
National Institutes of Health K01 Career Development Award (NIH/NIA AG052627) - Gustavus Adolphus College Decade Award
Gustavus Adolphus College Decade Award - BIDMC/National Institutes of Aging T32 Translational Research in Aging Award
BIDMC/National Institutes of Aging T32 Translational Research in Aging Award